- blocking peptide
- coli recombinant
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.
- The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs.
- What Drives Innovation: The Canadian Touch on Liposomal Therapeutics.
DM us for scientific support 8AM - 1AM UTC Mon - Fri. Serving life science researchers globally to achieve their mission, faster.
Our first summer school on #chromatin biology kicks off today: an exciting 12-day training packed with lectures from #epigenetics leaders, practical courses, knowledge-sharing, and networking. Many thanks, @METorresPadilla, @robert_ife, Aloys Schepers for hosting and organizing!2
Congratulations to the teams at @KirOxford @InflamAge_UoB @BrighamResearch on this exciting publication. Great use of #scRNA-seq and #CellDIVE #multiplex tissue imaging to reveal two types of #fibroblasts shared across 4 chronic #inflammatory diseases. ➡️ https://www.cell.com/med/fulltext/S2666-6340(22)00184-2
⏰ Deadline approaching:
Join @laoneill111 and @evanna_mills and present at our upcoming #immunometabolism conference in #Boston, Nov 7-8. Submit your abstract for a talk before Sept 1 – here 👇
@DanaFarber @harvardmed @tcdbi
We know that high-quality reagents speed up progress. That’s why we’re passionate about providing solutions that give accurate and reproducible results from the start. See how our dedication to quality boosts your research. https://www.abcam.com/content/quality-reagents-mean-faster-progress
Great to catch up with @PoulogiannisLab at the #Cancer & #Metabolism conference. #ICYMI, here is a digest prepared with one of the scientific organizers @OMaddocks https://tipbox.abcam.com/cancer-and-metabolism-2022/
@ICR_London @TheCrick @GottliebLab @LabVousden